Results 41 to 50 of about 6,542,588 (257)
The influence of growth hormone deficiency on bone health and metabolism
, 2023 Growth hormone (GH) is a key peptide hormone in the regulation of bone metabolism, through its systemic and paracrine action mediated directly as well as by insulin-like growth factor-1 (IGF-1).
Jakub Wydra +3 more
core +1 more source
JCRPE, 2023 IGSF1 deficiency is a rare X-linked condition characterized by central hypothyroidism and a wide variety of other clinical features with variable prevalence, including a delayed pubertal testosterone rise and growth spurt in the context of normal or ...
Aslı Derya Kardelen +7 more
doaj +1 more source
Clinical and Translational Radiation Oncology, 2022 Purpose: Pediatric brain tumor patients are vulnerable to radiotherapy (RT) sequelae including endocrinopathies. We compared post-RT neuroendocrine outcomes between pediatric brain tumor patients receiving photons (XRT) versus protons (PRT).
Anthony T. Yip +10 more
doaj +1 more source
Experience of switching from a daily to a less frequent administration of injection treatments
PLoS ONE, 2022 Background Daily injections of recombinant human growth hormone are the standard of care to treat growth failure due to pediatric growth hormone deficiency (GHD). While effective, daily injections are burdensome and can compromise adherence.
Jane Loftus +6 more
doaj +2 more sources
Linear Growth in Children With Growth Hormone Deficiency: Interaction of Growth Hormone, Somatostatin and Amino Acids [PDF]
, 1990 Thirty two children (twenty one boys and eleven girls) whose ages ranged from 2.17 to 17.94 years were identified as having growth hormone deficiency. Of these, nineteen (fourteen boys and five girls) had idiopathic growth hormone deficiency, while in ...
Smeda, Smeda Hassan
core +5 more sources
Children, 2022 Introduction: Brain tumors are the second most frequent type of all pediatric malignancies. Depending on their localization, patients with brain tumors may present neurological or ophthalmological symptoms, but also weight anomalies and endocrine ...
Fabien Claude +2 more
doaj +1 more source
Management of growth hormone deficiency in adults
, 2007 Growth hormone (GH) deficiency in adults is a recognised clinical entity. There is still, however, an ongoing debate of the clinical need and the importance of replacing GH in adults with severe GH deficiency.
Nilsson, Anna G, +2 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.
Karen Schow Jensen +10 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric intramedullary low‐grade gliomas (PIMLGGs) are rare neoplasms that present unique clinical and management challenges. Although surgery remains the primary tool for tissue diagnosis and decompression, complete gross‐total resection is frequently unfeasible due to the infiltrative nature of these lesions.
Olga M. Sergeenko +5 more
wiley +1 more source